[1] |
HE XY, SHI J. Consensus opinion on medical treatment of chronic cholecystitis and cholecystolithiasis in China (2018)[J]. J Clin Hepatol, 2019, 35(6): 1231-1236. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2015.01.002
何相宜, 施健. 中国慢性胆囊炎、胆囊结石内科诊疗共识意见(2018年)[J]. 临床肝胆病杂志, 2019, 35(6): 1231-1236. DOI: 10.3969/j.issn.1001-5256.2015.01.002
|
[2] |
KERLAN RK, LABERGE JM, RING EJ. Percutaneous cholecystolithotomy: Preliminary experience[J]. J Radiology, 1985, 157(3): 653-656. DOI: 10.1148/radiology.157.3.4059554
|
[3] |
CHESLYN-CURTIS S, RUSSELL RCG. Percutaneous cholecystolithotomy[J]. BMJ Clin Res, 1990, 301(6747): 339-340.
|
[4] |
LIEVENS M, SCHUTZ SM. Percutaneous cholecystolithotomy: Is gall stone recurrence inevitable?[J]. Gastrointest Endosc, 1995, 41(3): 271-272. http://europepmc.org/articles/PMC1374759
|
[5] |
TAN YY, ZHAO G, WANG D, et al. A new strategy of minimally invasive surgery for cholecystolithiasis: Calculi removal and gallbladder preservation[J]. Dig Surg, 2013, 30(4-6): 466-471. DOI: 10.1159/000357823
|
[6] |
GAO DK, WEI SH, LI W, et al. Totally laparoscopic gallbladder-preserving surgery: A minimally invasive and favorable approach for cholelithiasis[J]. Exp Ther Med, 2015, 9(2): 395-398. DOI: 10.3892/etm.2014.2107
|
[7] |
SAUERBREI W, ROYSTON P, BINDER H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building[J]. Stat Med, 2007, 26(30): 5512-5528. DOI: 10.1002/sim.3148
|
[8] |
FRIEDMAN J, HASTIE T, TIBSHIRANI R. Regularization paths for generalized linear models via coordinate descent[J]. J Stat Softw, 2010, 33(1): 1-22. http://neuro-oncology.oxfordjournals.org/external-ref?access_num=20808728&link_type=MED
|
[9] |
KIDD AC, MCGETTRICK M, TSIM S, et al. Survival prediction in mesothelioma using a scalable Lasso regression model: Instructions for use and initial performance using clinical predictors[J]. BMJ Open Respir Res, 2018, 5(1): e000240. DOI: 10.1136/bmjresp-2017-000240
|
[10] |
BALACHANDRAN VP, GONEN M, SMITH JJ, et al. Nomograms in oncology: More than meets the eye[J]. Lancet Oncol, 2015, 16(4): e173-e180. DOI: 10.1016/S1470-2045(14)71116-7
|
[11] |
IASONOS A, SCHRAG D, RAJ GV, et al. How to build and interpret a nomogram for cancer prognosis[J]. J Clin Oncol, 2008, 26(8): 1364-1370. DOI: 10.1200/JCO.2007.12.9791
|
[12] |
KRAMER AA, ZIMMERMAN JE. Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited[J]. Crit Care Med, 2007, 35(9): 2052-2056. DOI: 10.1097/01.CCM.0000275267.64078.B0
|
[13] |
PENCINA MJ, D'AGOSTINO RB. Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation[J]. Stat Med, 2004, 23(13): 2109-2123. DOI: 10.1002/sim.1802
|
[14] |
ANDREW JV, ANGEL MC, ELENA BE, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers[J]. BMC Medical Informatics and Decision Making, 2008, 8(15): 1039-1052. http://www.bmj.com/lookup/external-ref?access_num=10.1186/1472-6947-8-53&link_type=DOI
|
[15] |
Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer[J]. Science Foundation in China, 2016, 24(4): 35.
|
[16] |
HAN XM, SHU XC, WANG YP. Research progress on the correlation between cholecystolithiasis, cholecystectomy and gastric cancer[J]. Med Rev, 2020, 26(13): 2559-2563, 2569. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS202013013.htm
韩雪梅, 舒小闯, 王玉平, 等. 胆囊结石及胆囊切除与胃癌相关性研究进展[J]. 医学综述, 2020, 26(13): 2559-2563, 2569. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS202013013.htm
|
[17] |
WEI L, CHAMPMAN S, LI X, et al. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: A cross-sectional study in China[J]. BMJ Open, 2017, 7(10): e017293. DOI: 10.1136/bmjopen-2017-017293
|
[18] |
LI A, LIU JW, ZHANG D. Research progress on recurrence of cholecystolithiasis after endoscopic minimally invasive choledocholithiasis[J]. J Hepatopancreatobiliary Surg, 2019, 31(9): 573-577. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-GDYW201909017.htm
李骜, 刘江伟, 张东. 内镜微创保胆取石术后胆囊结石复发的研究进展[J]. 肝胆胰外科杂志, 2019, 31(9): 573-577. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYW201909017.htm
|
[19] |
CONDAT B, ZANDITENAS D, BARBU V, et al. Prevalence of low phospholipid-associated cholelithiasis in young female patients[J]. Dig Liver Dis, 2013, 45(11): 915-919. DOI: 10.1016/j.dld.2013.04.002
|
[20] |
GE HL, WAN H. Analysis of risk factors related to recurrence of gallstones after minimally invasive endoscopic choledocholithotomy[J]. J Binzhou Med Univ, 2016, 39(2): 149-150. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-BZYB201602024.htm
葛海龙, 万航. 微创内镜保胆取石术术后胆囊结石复发的相关危险因素分析[J]. 滨州医学院学报, 2016, 39(2): 149-150. https://www.cnki.com.cn/Article/CJFDTOTAL-BZYB201602024.htm
|
[21] |
van de MEEBERG PC, PORTINCASA P, van de HEIJNING BJM, et al. Gallbladder (GB) emptying in vivo and contractility in vitro of gallstone patients on ursodeoxycholic acid(UDCA)[J]. Neth J Med, 1996, 48(1): A39. http://www.sciencedirect.com/science/article/pii/0300297796896458
|
[22] |
LIU T, LI N, LI D, et al. Clinical study on Xiaoshi Lidan capsule combined with ursodeoxycholic acid in the treatment of cholecystolithiasis[J]. China Pharm, 2019, 28(8): 30-32. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YYGZ201908013.htm
刘彤, 李楠, 李栋, 等. 消石利胆胶囊联合熊去氧胆酸治疗胆囊结石临床研究[J]. 中国药业, 2019, 28(8): 30-32. https://www.cnki.com.cn/Article/CJFDTOTAL-YYGZ201908013.htm
|